Assessment of critical bioprocess parameters for broadly cross-reactive chimeric hemagglutinin influenza virus vaccines. Scherm MJ, Holzl R, Gonzalez-Dominguez I, Hjorth R, et al. Vaccine 2025;64:127671.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Scherm MJ, Holzl R, Gonzalez-Dominguez I, Hjorth R, et al. Assessment of critical bioprocess parameters for broadly cross-reactive chimeric hemagglutinin influenza virus vaccines. Vaccine 2025;64:127671.
PMID: 40972238